Title:
抗ＩＬ－３６Ｒ抗体製剤
Document Type and Number:
Japanese Patent JP2022524502
Kind Code:
A
Abstract:
本発明は、対象に投与するためのＩＬ－３６Ｒ製剤に関する。
Inventors:
Denkinger, Sandra Nicole
Steiner, Anna Maria
Katayama, Derrick Spencer
Maila, Rajni Prasad
Presser, Ingo Michael
Shin, Ravija
Wright, Sarah Kay
Steiner, Anna Maria
Katayama, Derrick Spencer
Maila, Rajni Prasad
Presser, Ingo Michael
Shin, Ravija
Wright, Sarah Kay
Application Number:
JP2021552832A
Publication Date:
May 06, 2022
Filing Date:
March 05, 2020
Export Citation:
Assignee:
Boehringer Ingelheim International Gesellschaft Mitt Beschlenktel Haftung
International Classes:
A61K39/395; A61K9/08; A61K9/19; A61K47/02; A61K47/10; A61K47/12; A61K47/18; A61K47/26; A61K47/34; A61P37/02
Domestic Patent References:
| JP2018512157A | 2018-05-17 | |||
| JP2015500633A | 2015-01-08 | |||
| JP2002504907A | 2002-02-12 | |||
| JP2007524602A | 2007-08-30 |
Foreign References:
| US20120121580A1 | 2012-05-17 |
Attorney, Agent or Firm:
Patent business corporation Tsukuni
Previous Patent: Low density amorphous sugar
Next Patent: Percutaneous antimicrobial flora preparation
Next Patent: Percutaneous antimicrobial flora preparation